Usually RS's scare me out, but not at these levels. I got out of GNTA at .078 and it tripled after it's RS and only fell because of bad phase 3 data. If IDOI tripled after a RS from here, I'd be VERY HAPPY, but unlike biotech, we'd have a product in use, instead of phase data.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.